1. Purpose

Anilocus Inc. is committed to transparency regarding our ownership structure, funding sources, and governance. This disclosure is provided as part of our commitment to accountability.

2. Corporate Structure

Anilocus Inc. is a privately held corporation organized under the laws of the State of Maryland. Our registered address is 20271 Goldenrod Lane Ste 2086, Germantown, Maryland 20876.

3. Ownership

Anilocus Inc. is privately owned by its founders and management team. The company is not publicly traded and does not have external equity investors beyond its founders and key personnel.

4. Funding Sources

Anilocus operations are funded through revenue from services, founder capital, and retained earnings. We do not currently receive funding from venture capital firms, private equity investors, or government grants that would compromise our independence.

5. Editorial Independence

Anilocus maintains full editorial independence in its published content. Our funding sources and ownership structure do not influence our editorial decisions, research findings, or service recommendations.

6. Research Independence

Our preclinical research services are conducted with scientific objectivity and integrity. Study results are reported accurately regardless of client preferences or commercial considerations.

7. Updates to This Disclosure

We will update this disclosure as our ownership structure or funding sources change materially.